Drug Study

Dopamine HCl
Valerie V. Villanueva BN3-C
Dosage,
Name of Drug Frequency, Mechanism of Action Indication Contraindication Adverse Effect Nursing Responsibility
Route
Generic Name: Dosage: Low dose (<3 mcg/kg/min): Shock: Moderate doses  Tachy-  Hypotension,  Correct hypovolemia with
Dopamine 400mg/500 activates dopaminergic enhance contractility dysrhythmias hypertension, fluid resuscitation before
hydrochloride ml receptors in kidneys producing increasing cardiac output;  Ventricular tachycardia initiating dopamine
renal artery dilation. High doses produce fibrillation  Anginal pain, infusion.
Brand Name: Frequency: vasoconstriction to  Pheochromocyt ectopic beats,  Monitor blood pressure,
Dopamax 5 cc/hr Mid dose (3 – 10 mcg/kg/min): enhance blood pressure. oma vasoconstriction pulse, and peripheral pulses
primarily  Safety during (cold every 15 minutes.
Classification: Route: activates β1 adrenergic Heart Failure: At moderate pregnancy, extremities)  Monitor hourly urine
Inotropic Agents IVTT receptors in heart increasing doses, dopamine enhances lactation or with  Nausea, output.
heart rate (positive contractility. Higher doses children not vomiting,  Cardiac monitor should
chronotropic agent), exacerbate heart failure by established. headache be used on patients
contractility (positive inotropic increasing afterload and  Tissue necrosis receiving dopamine
agent) producing additional and sloughing if infusion.
workload on the heart. extravasation  Weigh patient daily to
High dose (10 – 20 occurs determine accurate infusion
mcg/kg/min): activates α- Bradycardia: Dopamine is dose.
adrenergic receptorsproducing a 2nd line drug after  Calculate infusion drips
vasoconstriction atropine for bradycardias. and doses carefully.
(increasing systemic vascular Double-check calculations
resistance or left ventricular with another nurse or
afterload) pharmacist.
 IV site should not be used
for any other infusions or IV
therapies.

This study source was downloaded by 100000808020128 from CourseHero.com on 02-21-2022 05:05:24 GMT -06:00
 This study source was downloaded by 100000808020128 from CourseHero.com on 02-21-2022 05:05:24 GMT -06:00
Powered by TCPDF (www.tcpdf.org)